期刊文献+

注射用尤瑞克林治疗进展性脑梗死疗效分析 被引量:2

下载PDF
导出
摘要 进展性脑梗死是指发病后神经缺损症状轻微,但呈渐进性加重,在48h内仍不断进展,直至出现较严重的神经功能缺损的急性缺血性脑卒中,约占脑梗死的26%~43%;其病死率和致残率较高,常规治疗效果不理想,本文应用尤瑞克林治疗进展性脑梗死,疗效较好,现报告如下。
出处 《心脑血管病防治》 2011年第2期150-151,共2页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献9

  • 1王维治,主编.神经病学[M].第5版.北京:人民卫生版社,2004:307-308.
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15761
  • 3孟家眉.脑卒中患者临床神经缺损程度评分标准(改良爱丁堡与斯堪的那维亚研究组标准).中华神经科杂志,1988,21(1):57-58.
  • 4Thanvi B,Treadwell S,Robinson T.Early neurological deterioration in acute ischaemic stroke:predictiors,mechanisms andmanagement[J].Postgrad Med J,2008,84(994):412-417.
  • 5Nagano H,Suzuki T,Nakamura S,et al.Pharmacological studies on human urinary kallidinogenase (SK-827):cerebral protective effects[J].Yakugaku Zasshi,1993,113(11):803-809.
  • 6李晓莉 侯永敏.治疗急性脑卒中新药-凯力康.新药窗,2007,11(44):69-72.
  • 7石秦东,张军峰,张蓬勃,王雪,陈新林,田玉梅,杨蓬勃,张建水,刘勇.尤瑞克林对大鼠局灶性脑缺血半暗带脑血流量影响的研究[J].中国神经精神疾病杂志,2008,34(7):413-416. 被引量:75
  • 8Emanueli C,Madeddu P.Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases[J].Arch Mal Coeur,2004,97(6):679-687.
  • 9Xia C F,Yin H,Borlongan C V,et al.Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis[J].Hypertension,2004,43(2):452-459.

二级参考文献12

  • 1屈志炜,苏丹,张丽英,吴俊芳,巫锦娣,王晓岩,谢永立.凯力康对大鼠局灶性脑缺血的实验研究[J].中国处方药,2005,4(11):73-75. 被引量:43
  • 2Tobias B. Pathophysiology of the ischemic penumbra-revision of a concept [ J ]. Cell Mol Neurobiol, 1998, 18 (6) : 621 - 638.
  • 3Koizumi J, Yoshida Y, Nakazawa T, et al. Experimental studies of ischemic brain edema: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area[J]. Jpn Stroke J, 1986, 8(1) : 1 -8.
  • 4Stenman E,Jamali R, Henriksson M, et al. Cooperative effect of angiotensin AT1 and endothelin ETA receptor antagonism limits the brain damage after ischemic stroke in rat[ J]. European Journal of Phamaeology, 2007,570( 1 -3 ) : 142 - 148.
  • 5Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion [J]. Stroke, 1989, 20(8): 1037-1043.
  • 6Klasner B, Lumenta DB, Pruneau D, et al. therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats [ J ]. Neurochemistry international, 2006, 49 (5) : 442 - 447.
  • 7Iwanami J, Mogi M, Okamoto S, et al. Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model[ J]. European J pharmacology, 2007, 566 (1 - 3) :153 - 159.
  • 8Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke[ J]. Nat Med,2000,6(2) : 159 - 163.
  • 9Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology stroke: lessions from animal models [ J ]. Metabolic brain disease, 2004, 19(3/4 ) : 151 - 167.
  • 10Reglodi D,. Tamas A, Lengvari I. Examination of sensorimotor performance following middle cerebral artery occlusion in rat [ J ]. Brain Research Bulletin, 2002, 59 (6) :459 - 466.

共引文献15995

同被引文献28

  • 1江名芳,杨志生.疏血通与尤瑞克林联合应用治疗急性脑梗死的疗效观察[J].内蒙古医科大学学报,2011,33(S1):580-582. 被引量:1
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33053
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15761
  • 4丁德云,吕传真,丁美萍,苏炳华,陈峰.人尿激肽原酶治疗急性脑梗死多中心随机双盲安慰剂对照试验[J].中华神经科杂志,2007,40(5):306-310. 被引量:169
  • 5Storini C,Bergamaschini L,Gesuete R,et al.Selective inhi-bition ofPlasma kallikreinProtects brain from reperfusion injury[J].JPharmacol Exp Ther,2006,318(2):849-854.
  • 6Xia CF,Yin H,Borlongan CV,et al.Kallikrein gene transferProtects against ischemic stroke byPromoting glial cell migration and inhibitingapoptosis[J].Hypertension,2004,43(2):452-459.
  • 7Nagano H,Suzuki T,Tomogufi T,et al.Pharmacological stud-ies on human urinary kallidinogenase(SK-827):efects on ce-rebral metabolism[J].Yakugaku Zasshi,1993,113(11):825-828.
  • 8Campbell DJ.The kallikrein-kinin system in humans[J].Clin ExpPharmacolPhysiol,200l,28(12):l060-1065.
  • 9Nagano H,Suzuki T,Nakamuru S,et al.Pharmacological stud-ies on human urinary kallidinogenase(SK-827):cerebralPro-tective efects[J].Yakugaku Zasshi,l993,1l3(11):803-809.
  • 10Ling L,Hou Q,Xing S,et al.Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and thePeri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats[J].Brain Res,2008,1206:89-97.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部